Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00045032 |
|---|---|
| Brief Title: | Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer (HERA) |
| First Submitted : | September 6, 2002 |
| First Submitted that Met QC Criteria : | January 26, 2003 |
| First Posted : | January 27, 2003 (Estimate) |
| Results First Submitted : | October 19, 2016 |
| Results First Submitted that Met QC Criteria : | March 17, 2017 |
| Results First Posted : | April 27, 2017 |
| Last Update Submitted that Met QC Criteria : | March 17, 2017 |
| Last Update Posted : | April 27, 2017 |